JPH0424331B2 - - Google Patents

Info

Publication number
JPH0424331B2
JPH0424331B2 JP60293195A JP29319585A JPH0424331B2 JP H0424331 B2 JPH0424331 B2 JP H0424331B2 JP 60293195 A JP60293195 A JP 60293195A JP 29319585 A JP29319585 A JP 29319585A JP H0424331 B2 JPH0424331 B2 JP H0424331B2
Authority
JP
Japan
Prior art keywords
plasminogen
solubility
preparation
present
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60293195A
Other languages
English (en)
Japanese (ja)
Other versions
JPS62153224A (ja
Inventor
Kenji Tanaka
Minoru Tsukada
Yoshiro Iga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GC Biopharma Corp
Original Assignee
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Korea filed Critical Green Cross Corp Korea
Priority to JP60293195A priority Critical patent/JPS62153224A/ja
Publication of JPS62153224A publication Critical patent/JPS62153224A/ja
Publication of JPH0424331B2 publication Critical patent/JPH0424331B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP60293195A 1985-12-27 1985-12-27 プラスミノゲン製剤 Granted JPS62153224A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60293195A JPS62153224A (ja) 1985-12-27 1985-12-27 プラスミノゲン製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60293195A JPS62153224A (ja) 1985-12-27 1985-12-27 プラスミノゲン製剤

Publications (2)

Publication Number Publication Date
JPS62153224A JPS62153224A (ja) 1987-07-08
JPH0424331B2 true JPH0424331B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-04-24

Family

ID=17791645

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60293195A Granted JPS62153224A (ja) 1985-12-27 1985-12-27 プラスミノゲン製剤

Country Status (1)

Country Link
JP (1) JPS62153224A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06211691A (ja) * 1993-01-11 1994-08-02 Green Cross Corp:The プラスミノゲン乾燥製剤
KR102692851B1 (ko) 2014-12-19 2024-08-06 프로메틱 바이오 테라퓨틱스 인코포레이티드 플라스미노겐을 포함하는 약학 조성물 및 이의 용도
ES2968254T3 (es) 2015-12-18 2024-05-08 Talengen Int Ltd Plasminógeno para su uso en la prevención o el tratamiento de la trombosis aguda y la trombosis crónica
EP3556385A4 (en) 2016-12-15 2020-12-30 Talengen International Limited PROCESS FOR ALLEGING HEART DISEASE
US11207387B2 (en) 2016-12-15 2021-12-28 Talengen International Limited Method and drug for preventing and treating obesity
JP7160351B2 (ja) 2016-12-15 2022-10-25 タレンゲン インターナショナル リミテッド 脂肪代謝障害およびその関連疾患を予防および治療するための方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119157A1 (de) * 1981-05-14 1982-12-09 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von und danach hergestelltes plasminogen

Also Published As

Publication number Publication date
JPS62153224A (ja) 1987-07-08

Similar Documents

Publication Publication Date Title
EP0444692B1 (en) Thrombin composition for oral administration
US10898553B2 (en) Pharmaceutical composition comprising plasminogen and uses thereof
JP3530300B2 (ja) 安定なトランスグルタミナーゼ製剤およびそれらを製造する方法
FI85334C (fi) Foerfarande foer framstaellning av en vattenbaserad, vaevnadsplasminogenaktivator (t-pa) innehaollande, koncentrerad parenterad loesning.
FI85335B (fi) Foerfarande foer framstaellning av lyofiliserad, farmaceutisk vaevnadsplasminogenaktivator(t-pa)-komposition.
JP5253501B2 (ja) 安定化トロンビン組成物
CA1340270C (en) Thrombolytic composition and a process for production thereof
JP3143470B2 (ja) ポリペプチド含有の皮下または筋肉内投与用医薬組成物
JPS60188328A (ja) インターフエロン投与用ビヒクル
JPS6236502B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2636499B2 (ja) プラスミノーゲン活性化因子蛋白の薬学的組成物
JPH0424331B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPH06247872A (ja) 高濃度ｔｃｆ製剤
JP2715104B2 (ja) トロンビン乾燥製剤
CA2046598C (en) T-pa solubilisation
JPH0296536A (ja) プラスミノゲン乾燥製剤
JPS62234030A (ja) ｔＰＡ医薬組成物
JPH0369332B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU2218934C2 (ru) Препарат интерферона
JP4025394B2 (ja) 組織プラスミノーゲン活性化因子医薬組成物
JP2717638B2 (ja) 人血液凝固第ｉｘ因子含有製剤
JPS59139323A (ja) ウロキナ−ゼ乾燥製剤
WO1992011022A1 (en) Pharmaceutical preparation for pernasal administration
JPS604718B2 (ja) 安定なウロキナーゼ組成物およびその製造法
JPH06211691A (ja) プラスミノゲン乾燥製剤